DB17 Stock Overview
Xtrackers - MSCI EMU UCITS ETF is an exchange traded fund launched by Deutsche Asset Management S.A.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Xtrackers - MSCI EMU UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£52.38 |
52 Week High | UK£52.92 |
52 Week Low | UK£42.77 |
Beta | 0 |
1 Month Change | -0.11% |
3 Month Change | 7.81% |
1 Year Change | 11.83% |
3 Year Change | 15.34% |
5 Year Change | 30.87% |
Change since IPO | 27.65% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
DB17 | AT Capital Markets | AT Market | |
---|---|---|---|
7D | 2.1% | -2.7% | -0.04% |
1Y | 11.8% | 14.9% | 2.2% |
Return vs Industry: DB17 underperformed the Austrian Capital Markets industry which returned 14.9% over the past year.
Return vs Market: DB17 exceeded the Austrian Market which returned 2.2% over the past year.
Price Volatility
DB17 volatility | |
---|---|
DB17 Average Weekly Movement | 1.3% |
Capital Markets Industry Average Movement | 4.0% |
Market Average Movement | 3.3% |
10% most volatile stocks in AT Market | 5.0% |
10% least volatile stocks in AT Market | 1.6% |
Stable Share Price: DB17 has not had significant price volatility in the past 3 months.
Volatility Over Time: DB17's weekly volatility (1%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | n/a | n/a | n/a |
Xtrackers - MSCI EMU UCITS ETF is an exchange traded fund launched by Deutsche Asset Management S.A. It is managed by State Street Global Advisors Limited. The fund invests in the public equity markets of the European Economic and Monetary Union (EMU).
Xtrackers - MSCI EMU UCITS ETF Fundamentals Summary
DB17 fundamental statistics | |
---|---|
Market cap | €1.45b |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs DB17 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DB17 income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did DB17 perform over the long term?
See historical performance and comparison